# Marketing Status Notifications Under Section 506I of the Federal Food, Drug, and Cosmetic Act - FDA Guidance Document Source: https://www.globalkeysolutions.net/guidances/guidance-document/marketing-status-notifications-under-section-506i-of-the-federal-food-drug-and-cosmetic-act/3ac0774c-4c44-47b4-a602-7f011b30b3b0 > FDA guidance document: Marketing Status Notifications Under Section 506I of the Federal Food, Drug, and Cosmetic Act. Issue date: August 10, 2020. Get complete insights and analysis. --- ## Details - Title: Marketing Status Notifications Under Section 506I of the Federal Food, Drug, and Cosmetic Act - Communication Type: Guidance Document - Product Type: drugs - Office Name: Center for Drug Evaluation and Research - Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c - Issue Date: 2020-08-10 - Last Changed: 2020-08-10 - Docket Number: FDA-2018-D-4615 ## Related Documents - [Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act](https://www.globalkeysolutions.net/guidances/guidance-document/evaluation-of-bulk-drug-substances-nominated-for-use-in-compounding-under-section-503b-of-the-federal-food-drug-and-cosmetic-act/32f6b565-3151-4e63-8311-63f0e604bece) - [Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/compounded-drug-products-that-are-essentially-copies-of-a-commercially-available-drug-product-under-section-503a-of-the-federal-food-drug-and-cosmetic-act-guidance-for-industry/57a1209c-86f8-4813-bb35-0bd3d8265bc2) - [Facility Definition Under Section 503B of the Federal Food, Drug, and Cosmetic Act](https://www.globalkeysolutions.net/guidances/guidance-document/facility-definition-under-section-503b-of-the-federal-food-drug-and-cosmetic-act/0757072b-35f4-40f5-97ac-c401faa17cb3)